ArticleAnnals of translational medicine2022

Efficacy and safety of apatinib in advanced refractory soft tissue sarcoma and association with histologic subtypes: a multicenter retrospective study.

Xiangling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.